- ACTIVE INGREDIENT
- PURPOSE
- WARNINGS
- ASK DOCTOR
- WHEN USING
- STOP USE
- KEEP OUT OF REACH OF CHILDREN
- INDICATIONS & USAGE
- STORAGE AND HANDLING
- INACTIVE INGREDIENT
- DOSAGE & ADMINISTRATION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
BABYO2
colloidal silver and glycerin solutionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:72136-005 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SILVER (UNII: 3M4G523W1G) (SILVER - UNII:3M4G523W1G) SILVER 2 mg in 240 mL GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN 2 mg in 240 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) SODIUM CHLORIDE NA-22 (UNII: VMP9781061) HYDROXYPROPYL CORN STARCH (5% SUBSTITUTION BY WEIGHT) (UNII: 9M44R3409A) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72136-005-01 240 mL in 1 TUBE; Type 0: Not a Combination Product 02/26/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 02/26/2019 Labeler - Oxigenesis, Inc. (006774725) Registrant - Oxigenesis, Inc. (006774725) Establishment Name Address ID/FEI Business Operations Oxigenesis, Inc. 006774725 manufacture(72136-005)